1
|
Lai S, Kumari A, Liu J, Zhang Y, Zhang W, Yen K, Xu J. Chemical screening reveals Ronidazole is a superior prodrug to Metronidazole for nitroreductase-induced cell ablation system in zebrafish larvae. J Genet Genomics 2021; 48:1081-1090. [PMID: 34411714 DOI: 10.1016/j.jgg.2021.07.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2021] [Revised: 07/21/2021] [Accepted: 07/26/2021] [Indexed: 10/20/2022]
Abstract
The Metronidazole (MTZ)/nitroreductase (NTR)-mediated cell ablation system is the most commonly used chemical-genetic cell ablation method in zebrafish. This system can specifically ablate target cells under spatial and temporal control. The MTZ/NTR system has become a widely used cell ablation system in biological, developmental, and functional studies. However, the inadequate cell-ablation ability of some cell types and the side effects of high concentration MTZ impede extensive applications of the MTZ/NTR system. In the present study, the US drug collection library was searched to extend the NTR system. Six MTZ analogs were found, and the cell-ablation ability of these analogs was tested in zebrafish larvae. The results revealed that two of the NTR substrates, Furazolidone and Ronidazole, ablated target cells more efficiently than MTZ at lower concentrations. Furthermore, the working concentration of Ronidazole, but not Furazolidone and MTZ, did not affect axonal bridge formation during spinal cord regeneration. Our results, taken together, indicate that Ronidazole is a superior prodrug to MTZ for the NTR system, especially for the study of neuron regeneration in zebrafish larvae.
Collapse
Affiliation(s)
- Siting Lai
- Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Ankita Kumari
- Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou 510006, China
| | - Jixiang Liu
- Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou 510006, China
| | - Yiyue Zhang
- Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou 510006, China
| | - Wenqing Zhang
- Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou 510006, China
| | - Kuangyu Yen
- Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
| | - Jin Xu
- Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou 510006, China.
| |
Collapse
|
2
|
Hedgespeth BA, Stauffer SH, Robertson JB, Gookin JL. Association of fecal sample collection technique and treatment history with Tritrichomonas foetus polymerase chain reaction test results in 1717 cats. J Vet Intern Med 2020; 34:734-741. [PMID: 32039505 PMCID: PMC7096610 DOI: 10.1111/jvim.15727] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2019] [Accepted: 01/31/2020] [Indexed: 01/18/2023] Open
Abstract
BACKGROUND Fecal polymerase chain reaction (PCR) testing for Tritrichomonas foetus is considered the most sensitive means for diagnosis of infection but results could be influenced by fecal collection technique and prior use of antimicrobial drugs. OBJECTIVES To establish any association between fecal collection technique or treatment history and results of fecal PCR testing for T. foetus. ANIMALS Fecal samples from 1717 cats submitted by veterinarians between January 2012 and December 2017. METHODS This study used a retrospective analysis. T. foetus PCR test results from 1808 fecal samples submitted for diagnostic testing were examined for their association with method of fecal collection and prior antimicrobial treatments. Data were collected from sample submission form. RESULTS Positive T. foetus PCR test results were obtained for 274 (16%) cats. Fecal samples collected via fecal loop had increased probability of positive PCR test results (odds ratio [OR] 2.04, 95% confidence interval [CI] 1.31-3.17, P = .002) compared to samples collected by colonic flush. There was no association between PCR test results and treatment history, treatment type, or prior treatment with ronidazole. After an initial positive PCR test, 4/19 (21%; 95% CI 2.7%-39.4%) cats treated with ronidazole had a second positive test result. CONCLUSIONS AND CLINICAL IMPORTANCE Results of this study support that fecal samples collected by loop might be better for PCR diagnosis of T. foetus infection. Lack of association of ronidazole with PCR test results and a 21% all-potential-causes failure rate of ronidazole in cats with preconfirmed infection are important limitations to use of this drug.
Collapse
Affiliation(s)
- Barry A. Hedgespeth
- Department of Clinical SciencesNorth Carolina State UniversityRaleighNorth Carolina
| | - Stephen H. Stauffer
- Department of Clinical SciencesNorth Carolina State UniversityRaleighNorth Carolina
| | - James B. Robertson
- College of Veterinary MedicineNorth Carolina State UniversityRaleighNorth Carolina
| | - Jody L. Gookin
- Department of Clinical SciencesNorth Carolina State UniversityRaleighNorth Carolina
| |
Collapse
|
3
|
Le Roux D, Djokic V, Morisse S, Chauvin C, Doré V, Lagrée AC, Voisin D, Villain Y, Grasset-Chevillot A, Boursin F, Su C, Perrot S, Vallée I, Seche E, Blaga R. Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host. Vaccine 2019; 38:1457-1466. [PMID: 31864855 DOI: 10.1016/j.vaccine.2019.11.076] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2019] [Revised: 11/18/2019] [Accepted: 11/27/2019] [Indexed: 01/12/2023]
Abstract
Toxoplasmosis is a zoonotic disease caused by the parasite Toxoplasma gondii. Up to a third of the global human population is estimated to carry a T. gondii infection, which can result in severe complications in immunocompromised individuals and pregnant women. Humans and animals can become infected by ingesting either tissue cysts containing T. gondii bradyzoites, from raw or undercooked meat, or sporulated oocysts from environmental sources. T. gondii oocysts are released in the faeces of cats and other felids, which are the parasite's definitive hosts, leading to environmental contamination. Therefore, vaccination of the feline host against T. gondii is an interesting strategy to interrupt the parasitic life cycle and subsequently limit contamination of intermediate hosts. With this goal in mind, we tested in cats, an attenuated live strain of T. gondii deleted for the Mic1 and Mic3 genes (Mic1-3KO) that was previously shown to be an efficient vaccine candidate in mouse and sheep models. Subcutaneous or oral vaccination routes induced a high specific antibody titer in the cat sera, indicating that the Mic1-3KO strain is immunogenic for cats. To assess protection induced by the vaccine candidate strain, we followed oocysts shedding by vaccinated cats, after oral challenge with a T. gondii wild-type strain. Surprisingly, a high antibody titer did not prevent cats from shedding oocysts from the challenge strain, regardless of the vaccination route. Our results show that the Mic1-3KO vaccine candidate is immunogenic in the feline host, is well tolerated and safe, but does not confer protection against oocysts shedding after natural infection with wild type T. gondii. This result highlights the particular relationship between T. gondii and its unique definitive host, which indicates the need for further investigations to improve vaccination strategies to limit environmental and livestock contaminations.
Collapse
Affiliation(s)
- Delphine Le Roux
- UMR BIPAR, INRAE, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort, F-94700, France.
| | - Vitomir Djokic
- UMR BIPAR, INRAE, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort, F-94700, France
| | - Solen Morisse
- Vitamféro, Université François Rabelais - UFR des Sciences Pharmaceutiques, Tours, F-37200, France
| | - Clément Chauvin
- UMR BIPAR, INRAE, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort, F-94700, France
| | - Vanessa Doré
- BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, F-94700, France
| | - Anne-Claire Lagrée
- UMR BIPAR, INRAE, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort, F-94700, France
| | - Déborah Voisin
- UMR BIPAR, INRAE, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort, F-94700, France
| | - Yohan Villain
- UMR BIPAR, INRAE, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort, F-94700, France
| | - Aurélie Grasset-Chevillot
- UMR BIPAR, Anses, Ecole Nationale Vétérinaire d'Alfort, INRAE, Laboratoire de Santé Animale, Maisons-Alfort, F-94700, France
| | - Fanny Boursin
- Vitamféro, Université François Rabelais - UFR des Sciences Pharmaceutiques, Tours, F-37200, France
| | - Chunlei Su
- Department of Microbiology, University of Tennessee, Knoxville, United States of America
| | - Sébastien Perrot
- BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, F-94700, France
| | - Isabelle Vallée
- UMR BIPAR, Anses, Ecole Nationale Vétérinaire d'Alfort, INRAE, Laboratoire de Santé Animale, Maisons-Alfort, F-94700, France
| | - Edouard Seche
- Vitamféro, Université François Rabelais - UFR des Sciences Pharmaceutiques, Tours, F-37200, France
| | - Radu Blaga
- UMR BIPAR, INRAE, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort, F-94700, France
| |
Collapse
|
4
|
Hinney B, Christen I, Jähne S, Gaisbauer S, Schrammel N, Markl A, Joachim A, Künzel F. Efficacy and safety of ronidazole treatment against Tritrichomonas foetus in a cat colony with multiple disorders. VETERINARY PARASITOLOGY- REGIONAL STUDIES AND REPORTS 2019; 18:100344. [PMID: 31796193 DOI: 10.1016/j.vprsr.2019.100344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/04/2019] [Revised: 10/09/2019] [Accepted: 10/14/2019] [Indexed: 10/25/2022]
Abstract
In a group of pedigree cats (n = 17) in poor health condition housed in an animal shelter in Vienna, Austria, with a history of persistent diarrhea, Tritrichomonas foetus infection was detected by PCR. Despite pre-existing clinical conditions all cats were treated with ronidazole (30 mg/kg PO q24h for 14 days) under close observation. After treatment, 11 of 14 initially positive animals remained negative for T. foetus during the observation period (six to eight weeks post treatment) and no diarrhea was observed. During treatment, nine cats showed mild to moderate neurological disorders (incoordination, mild tremor) at least once; six of these had already shown similar signs before treatment. Ronidazole treatment of multimorbid animals is acceptable if the benefit (here: clinical resolution and release from quarantine for adoption) is high. It is hypothesized that a high degree of inbreeding is a significant risk factor for the development of tritrichomonosis in cats.
Collapse
Affiliation(s)
- Barbara Hinney
- Institute of Parasitology, Department of Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria.
| | - Isabelle Christen
- Institute of Parasitology, Department of Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Stéphanie Jähne
- Institute of Parasitology, Department of Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Stefanie Gaisbauer
- Clinical Unit of Internal Medicine Small Animals, University Hospital for Small Animals, Department/Hospital for Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Nadine Schrammel
- Department/Hospital for Companion Animals and Horses, University Hospital for Small Animals, Clinical Unit of Obstetrics, Gynaecology and Andrology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Andrea Markl
- Department/Hospital for Companion Animals and Horses, University Hospital for Small Animals, Clinical Unit of Obstetrics, Gynaecology and Andrology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Anja Joachim
- Institute of Parasitology, Department of Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria
| | - Frank Künzel
- Clinical Unit of Internal Medicine Small Animals, University Hospital for Small Animals, Department/Hospital for Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria
| |
Collapse
|
5
|
Characterization, Source and Risk of Pharmaceutically Active Compounds (PhACs) in the Snow Deposition Near Jiaozhou Bay, North China. APPLIED SCIENCES-BASEL 2019. [DOI: 10.3390/app9061078] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The occurrence and distribution of 110 pharmaceutically active compounds (PhACs) were investigated in snow near Jiaozhou Bay (JZB), North China. All target substances were analyzed using solid phase extraction followed by liquid chromatography coupled to tandem mass spectrometry.A total of 38 compounds were detected for the first time in snow, including 23 antibiotics, eight hormones, three nonsteroidal anti-inflammatory drugs, two antipsychotics, one beta-adrenergic receptor and one hypoglycemic drug. The total concentration of PhACs in snow ranged from 52.80 ng/L to 1616.02 ng/L. The compounds found at the highest mean concentrations included tetracycline (125.81 ng/L), desacetylcefotaxime (17.73 ng/L), ronidazole (8.79 ng/L) and triamcinolone diacetate (2.84 ng/L). The contribution of PhACs in the vicinity of JZB to the PhACs in the snow is far greater than the contribution of those transmitted over a long distance. PhACs are mainly derived from drugs applied to local humans and animals. Based on the individual risk quotient (RQ) values, tetracycline poses high risks to the relevant aquatic organisms (algae and invertebrates). The rational application and scientific management of PhACs is an effective approach to reduce the ecological risks in JZB.
Collapse
|